Brain Cancer Clinical Trials 2024

Brain Cancer Clinical Trials 2024

Brain Cancer research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in brain cancer clinical trials today.

Brain Cancer Clinical Trials

Here are the 6 most popular medical studies for brain cancer

Popular filter options for brain cancer trials

Brain Tumor Clinical Trials

View 61 Brain Tumor medical studies.

Diffuse Intrinsic Pontine Glioma Clinical Trials

View 61 Diffuse Intrinsic Pontine Glioma medical studies.

Metastatic Brain Cancer Clinical Trials

View 97 metastatic brain cancer medical studies.

Phase 3 Brain Cancer Clinical Trials

View 97 phase 3 brain cancer medical studies.

Brain Cancer Clinical Trials With No Placebo

View 97 brain cancer medical studies that do not have a placebo group.

View More Brain Cancer Trials

See another 70 medical studies focused on brain cancer.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to brain cancer

What are the top hospitals conducting brain cancer research?

When it comes to cutting-edge research on brain cancer, several hospitals across the United States are making significant strides. Memorial Sloan Kettering Cancer Center in New york leads the charge with 12 active clinical trials dedicated to brain cancer and a total of 52 completed trials since their first recorded trial in 2003. In Tampa, Moffitt Cancer Center is also at the forefront of brain cancer research, currently conducting nine ongoing clinical trials and having completed 22 studies since their inaugural trial in 2004.

Meanwhile, in Boston's prestigious Dana-Farber Cancer Institute, researchers are actively engaged in nine clinical trials focused on brain cancer. Their commitment extends beyond just current investigations; they have conducted a total of 31 studies since initiating their first trial back in 2002. Wake Forest University Health Sciences in Winston-Salem is another institution that has made significant contributions to advancing our understanding of brain cancer. With eight active trials and a total of sixteen previous studies dating back to their initial trial in 2004, they play an important role within this field.

In Urbana's Carle Cancer Center, while smaller-scale by comparison, researchers are making meaningful progress with six active clinical trials for brain cancer and fourteen completed trials thus far. Their journey started only eighteen years ago when they conducted their first recorded trial focusing on this complex condition.

These hospitals represent beacons of hope for those affected by brain cancer — places where innovative minds come together to unravel its mysteries through rigorous scientific exploration. By pushing boundaries and continuously endeavoring for breakthroughs, these institutions bring us closer to improved treatments and better outcomes for patients worldwide who bravely face this challenging disease every day

Which are the best cities for brain cancer clinical trials?

When it comes to brain cancer clinical trials, several cities emerge as top destinations for cutting-edge research. New york, with 39 active trials, Boston with 34 ongoing studies, and Los Angeles with 23 investigations offer promising opportunities for patients seeking innovative treatments. Additionally, Houston's contributions cannot be overlooked as it hosts 22 active trials focused on glioblastoma multiforme and other potential breakthroughs. Atlanta also presents a significant presence in the field of brain cancer research with its 20 ongoing studies. These cities provide individuals battling brain cancer access to groundbreaking clinical trials that pave the way for advancements in care and hope for improved outcomes.

Which are the top treatments for brain cancer being explored in clinical trials?

Exciting developments are underway in clinical trials as researchers explore new treatments for brain cancer. Nivolumab takes the lead with four active trials and 19 all-time brain cancer trials since its introduction in 2014. Similarly, a pharmacological study shows promise with four ongoing trials and 16 all-time brain cancer trials starting in 2003. Pembrolizumab follows closely behind, involved in three active trials and accumulating an impressive total of 17 all-time brain cancer studies since its listing in 2015. Rounding off the top contenders is stereotactic radiosurgery, currently being tested in three active trials and boasting an extensive history of involvement with a remarkable 37 all-time brain cancer studies dating back to 2004. These advancements offer hope for improved outcomes and brighter futures for patients battling this complex disease.

What are the most recent clinical trials for brain cancer?

Promising advancements are underway in the field of brain cancer research, with recent clinical trials offering hope for patients. One such trial focuses on NovoTTF-200A, a cutting-edge treatment that has progressed to Phase 1 and Phase 2 trials. Another study explores the potential benefits of RRx-001, currently in Phase 1 testing. Additionally, PET/CT and MRI imaging play crucial roles in a Phase 2 trial aimed at enhancing diagnostic capabilities for brain cancer. Furthermore, ongoing investigations into Nivolumab's efficacy through Phase 2 studies demonstrate continued efforts to improve treatment options for this challenging disease. These recent clinical trials signal encouraging progress in the fight against brain cancer and inspire optimism for better outcomes in the future

What brain cancer clinical trials were recently completed?

Recent advancements in brain cancer research have brought about the completion of several noteworthy clinical trials. In October 2020, a trial conducted by Blue Earth Diagnostics explored the potential of 18F fluciclovine as a diagnostic tool for brain cancer. Another trial involving the same sponsor and treatment was completed in August 2020, further contributing to our understanding of its efficacy. Emory University's investigation into WP1066 concluded in May 2020, shedding light on potential therapeutic options for this complex disease. These significant milestones underscore the tireless efforts of researchers striving to find improved treatments and diagnostics for individuals affected by brain cancer.